Aldebaran Financial Inc. Pfizer Inc Transaction History

Aldebaran Financial Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $14,440 - $16,879	450 Added 6.76%	7,109 $235,000
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $7,585 - $8,775	-210 Reduced 3.06%	6,659 $244,000
Q1 2023 Apr 24, 2023	SELL	$39.39 - $51.28 $28,400 - $36,972	-721 Reduced 9.5%	6,869 $280,000
Q4 2022 Mar 06, 2023	BUY	$41.75 - $54.5 $16,867 - $22,018	404 Added 5.62%	7,590 $389,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $21,792 - $26,603	498 Added 7.45%	7,186 $314,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $8,328 - $9,875	179 Added 2.75%	6,688 $344,000
Q1 2022 Apr 18, 2022	SELL	$45.75 - $56.69 $4,437 - $5,498	-97 Reduced 1.47%	6,509 $337,000
Q4 2021 Feb 16, 2022	BUY	$41.32 - $61.25 $165 - $245	4 Added 0.06%	6,606 $390,000
Q3 2021 Oct 21, 2021	BUY	$39.25 - $50.42 $35,482 - $45,579	904 Added 15.87%	6,602 $284,000
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $204,615 - $231,794	5,698 New	5,698 $225,000

3,271

3.63B

74.3M

107M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Aldebaran Financial Inc., based on Form 13F filings with the SEC.

Stay updated on Aldebaran Financial Inc. with notifications on news.